Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort

被引：0
|
作者：
Papillon-Cavanagh, Simon [1 ]
Gao, Chuan [1 ]
Han, G. Celine [1 ]
Walsh, Alice M. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2008
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts.
    Rieke, Damian Tobias
    De Bortoli, Till
    Benary, Manuela
    Horak, Peter
    Lamping, Mario
    Stintzing, Sebastian
    Tinhofer, Ingeborg
    Leyvraz, Serge
    Schaefer, Reinhold
    Klauschen, Frederick
    Keller, Ulrich
    Stenzinger, Albrecht
    Froehling, Stefan
    Kurzrock, Razelle
    Jelas, Ivan
    Keilholz, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] The combination of hyper-amplification and tumor mutational burden as a pan-cancer biomarker in patients treated with tislelizumab.
    Deva, Sanjeev
    Millward, Michael
    Friedlander, Michael
    Gan, Hui K.
    Hovarth, Lisa G.
    Lee, Jong-Seok
    Hill, Andrew
    Sandhu, Shahneen
    Liang, Liang
    Shi, Jingwen
    Zhang, Yun
    Shi, Yang
    Ma, Xiaopeng
    Wu, Xikun
    Shen, Zhirong
    Desai, Jayesh
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Development of a pan-cancer NGS assay for detection of tumor mutational burden and targeted biomarkers from FFPE samples
    Cyanam, Dinesh
    Mittal, Vinay
    Khazanov, Nickolay
    Williams, Paul
    Au-Young, Janice
    Bee, Gary
    El-Difrawy, Sameh
    Ewing, Aren
    Kilzer, Jennifer
    Kraltcheva, Anelia
    Myrand, Scott
    Tseng, Yu-Ting
    Van Loy, Cristina
    Wong-Ho, Elaine
    Yang, Chenchen
    Cyanam, Dinesh
    Bandla, Santhoshi
    Tom, Warren
    Sadis, Seth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [34] Association of a ctDNA biomarker of treatment response with clinical outcomes in a real-world pan-cancer cohort treated with tyrosine kinase inhibitors
    Mitra, Akash
    Guittar, John
    Schwind, Regina
    Driessen, Terri
    Berginski, Matthew
    Lo, Christine
    Stein, Michelle M.
    Freaney, Jonathan
    Hyun, Seung Won
    Sangli, Chithra
    Sasser, Kate
    Nimeiri, Halla
    Chaudhuri, Aadel
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Leveraging scale in precision oncology to measure pathway activation and detect genetic drivers in a large, real-world pan-cancer cohort
    Drews, Joshua
    Langer, Lee
    Karaesman, Ezgi
    MacKay, Matthew
    Sedgewick, Andrew
    Bell, Joshua
    Guinney, Justin
    Igartua, Catherine
    CANCER RESEARCH, 2023, 83 (07)
  • [36] Real-world concordance between tumor mutational burden (TMB) from blood (circulating tumor DNA) and tissue in lung cancer.
    Park, Inae
    Hwang, Jin Young
    Bae, William
    Lee, Grace
    Kim, Leeseul
    Choi, Yoonhee
    Jung, Hojung
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.
    Dong, Zhouhuan
    Gao, Jie
    Zhu, Fengwei
    Gai, Fei
    Su, Wenqing
    Liang, Zhixin
    Tian, Xiaodong
    Shi, Huaiyin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden
    Shemesh, Colby S.
    Chan, Phyllis
    Legrand, Fatema A.
    Shames, David S.
    Das Thakur, Meghna
    Shi, Jane
    Bailey, Lorna
    Vadhavkar, Shweta
    He, Xian
    Zhang, Wei
    Bruno, Rene
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (06):
  • [39] High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
    Jung, Jaeyun
    Heo, You Jeong
    Park, Sehhoon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (04)
  • [40] An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication
    Olivier Morin
    Martin Vallières
    Steve Braunstein
    Jorge Barrios Ginart
    Taman Upadhaya
    Henry C. Woodruff
    Alex Zwanenburg
    Avishek Chatterjee
    Javier E. Villanueva-Meyer
    Gilmer Valdes
    William Chen
    Julian C. Hong
    Sue S. Yom
    Timothy D. Solberg
    Steffen Löck
    Jan Seuntjens
    Catherine Park
    Philippe Lambin
    Nature Cancer, 2021, 2 : 709 - 722
12345